ABM vs HUBG

ABM's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at $38.77, significantly above its Graham Number of $41.41 and well below its intrinsic value estimate of $18.13, suggesting overvaluation relative to conservative metrics. Despite a 6.1% YoY revenue growth, earnings have declined by 7.2% YoY, and recent quarters have consistently missed estimates with an average surprise of -12.45%. Insider selling totaling $1.81M in the last six months further undermines confidence, while technical trends remain bearish.

HUBG exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.28. While the current price of $38.97 sits above the defensive Graham Number ($33.01), it remains well below the growth-based intrinsic value of $51.33. The company is successfully expanding margins, as evidenced by 20.5% earnings growth despite a 5.3% decline in revenue. Despite bearish technicals and recent insider selling, the long-term earnings track record and valuation metrics suggest significant upside.